Asia

WuXi Partners with Janssen to Meet GLP Standards in China Lab

Thursday, March 4, 2010 06:10 AM

Chinese CRO WuXi PharmaTech expanded its strategic collaboration with Johnson & Johnson Pharmaceutical Research and Development(a division of Janssen Pharmaceutica) to provide preclinical services to Janssen and to eventually offer Good Laboratory Practice (GLP) toxicology services at WuXi’s facility in Suzhou, China.

More... »

Quintiles Adds Anatomic Pathology Services to China Lab

Tuesday, February 23, 2010 07:49 AM

Quintiles added anatomic pathology to the service offerings it provides at its central laboratory in Beijing, China. The new services complement assay development, digital pathology and core lab offerings, which the Beijing facility already offers to help customers comply with China’s restrictions on tissue import and export.

More... »

UBC Opens First Office in Asia-Pac

Monday, February 15, 2010 04:51 PM

United BioSource Corporation’s (UBC’s) new office in Tokyo, Japan, is the company’s first office in that country and in all of Asia-Pacific.

More... »

SIRO Clinpharm Partners with DreamCIS in South Korea

Thursday, February 11, 2010 12:30 PM

Indian contract research organization (CRO) SIRO Clinpharm is partnering with South Korean CRO DreamCIS to expand SIRO’s services in the Asia-Pacific region.

More... »

StudyManager Expands into China

Friday, October 9, 2009 07:38 AM

StudyManager, a developer of integrated clinical trial management software (CTMS) and electronic data capture (EDC) solutions, recently expanded operations into China, resulting in sales of its sponsor edition product to two separate Chinese CROs.

More... »

PPD Opens Central Lab in Singapore

Tuesday, September 29, 2009 08:40 AM

PPD recently opened a new central lab facility in Singapore, where the CRO has had an office for more than 10 years. 

More... »

New CenterWatch Report Examines Japan’s Surging Clinical Trials Market

Wednesday, April 1, 2009 03:00 PM

In 2007, drug development in Japan, the world’s second largest pharmaceutical market, exploded six-fold over 2006 and should continue to grow, according to a new CenterWatch report released today.

More... »

WuXi Revenues Up 87% in 2008

Thursday, March 26, 2009 07:28 AM

Chinese contract research organization (CRO) WuXi Pharmatech reported an 87% increase in 2008 revenues compared with 2007, with net revenues for continuing operations of $253.5 million. Fourth-quarter 2008 net revenues from continuing operations increased 74% to $64.4 million compared with fourth quarter 2007. The CRO’s non-GAAP net income for 2008 was $58.3 million, up 31% from $44.6 million in 2007.

More... »

Quintiles Plans Phase I Unit in India

Wednesday, January 28, 2009 08:00 AM

Contract research organization (CRO) Quintiles is partnering with Apollo Hospitals Group in India to open a phase I clinical trial unit in Hyderabad, India.

More... »

AstraZeneca Bets More Chips On China

Wednesday, June 28, 2006 12:03 PM

AstraZeneca is investing $100 million more in China over the next three years to build the AstraZeneca Innovation Centre China, an R&D facility to study the benefits of new drugs to Chinese patients. Already one of the most heavily invested in China among big pharma companies, AstraZeneca is further distinguishing itself as the leader there with this new commitment.

More... »